95 related articles for article (PubMed ID: 5303765)
21. Prevention of experimental atherosclerosis with pyridinolcarbamate.
Wu CC; Huang TS; Hsu CJ
Am Heart J; 1969 May; 77(5):657-67. PubMed ID: 5778056
[No Abstract] [Full Text] [Related]
22. [Synthetic studies on antiatherogenic agents (III) syntheses of carbamate derivative of quinazolinones (author's transl)].
Ishikawa M; Egughi Y; Kaneshiro S
Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1975; 9():169-81. PubMed ID: 1076758
[No Abstract] [Full Text] [Related]
23. [Pyridinol carbamate, a new approach in the prevention and therapy of atherosclerosis].
Etchevés JC; Buzzi RM; Bruno E; Sacanell C
Hospital (Rio J); 1968 Sep; 74(3):807-14. PubMed ID: 5310120
[No Abstract] [Full Text] [Related]
24. Antiatherogenic effect of pyridinolcarbamate (prodectin). Experimental study.
Orbetzova V; Jurukova Z; Orbetzova M
Artery; 1980; 8(6):560-9. PubMed ID: 7259535
[TBL] [Abstract][Full Text] [Related]
25. The effect of clofibrate and pyridinol carbamate on the circulating immune complexes and cellular immune response in experimental atherosclerosis.
Szondy E; Horváth M; Füst G; Link E; Fehér J; Gerö S
Atherosclerosis; 1978 Nov; 31(3):251-7. PubMed ID: 718735
[TBL] [Abstract][Full Text] [Related]
26. Pyridinolcarbamate treatment of atherosclerosis obliterans analysed by toe plethysmography.
Motomiya T; Atsumi T; Isokane N; Yamashita S; Sano T
Jpn Heart J; 1970 Sep; 11(5):433-49. PubMed ID: 4921577
[No Abstract] [Full Text] [Related]
27. [Role of physiologically active substances in the pathogenesis and therapy of atherosclerosis].
Klimov AN
Vestn Akad Med Nauk SSSR; 1976; (9):48-50. PubMed ID: 1020445
[No Abstract] [Full Text] [Related]
28. [Preliminary study of a work concerning the activity of pyridinol carbamate on diabetic angiopathy (study of the microcirculation)].
Le Devehat C; Lemoine A
Journ Annu Diabetol Hotel Dieu; 1977; ():389-93. PubMed ID: 894879
[No Abstract] [Full Text] [Related]
29. Clinical and laboratory examinations with Prodectin.
Bédi J; Kosztovics A; Pálos LA
Ther Hung; 1976; 24(3):91-7. PubMed ID: 1013926
[No Abstract] [Full Text] [Related]
30. [Clinical experiences with pyridinolcarbamate in ophthalmology].
Musini A; Fabbri G; Tancini G
Ann Ottalmol Clin Ocul; 1969 Feb; 95(2):101-23. PubMed ID: 5398786
[No Abstract] [Full Text] [Related]
31. [Modifications of dyslipemia of atherosclerotic origin using pentosan polysulphonic ester].
Kabanchik M; Fernández F; Sermukslis B; Smud R; Palermo G
Prensa Med Argent; 1967 Dec; 54(39):2137-42. PubMed ID: 4901929
[No Abstract] [Full Text] [Related]
32. [New chemical substances for therapeutic use].
Clin Ter; 1970 Mar; 52(6):571-4. PubMed ID: 5452999
[No Abstract] [Full Text] [Related]
33. [Treatment of arteriosclerosis].
Knüchel F
Med Welt; 1969 Dec; 52():2817-8. PubMed ID: 5371544
[No Abstract] [Full Text] [Related]
34. [Synthetic studies on antiatherogenic agents (I). Syntheses of carbamate derivatives of diazines (author's transl)].
Ishikawa M; Eguchi Y
Tokyo Ika Shika Daigaku Iyo Kizai Kenkyusho Hokoku; 1974; 8():9-20. PubMed ID: 4534365
[No Abstract] [Full Text] [Related]
35. [Analysis of pyridinol carbamate. I. Gas chromatographic determination of pyridinol carbamate].
Laukó A; Görög S
Acta Pharm Hung; 1986 May; 56(3):129-32. PubMed ID: 3739725
[No Abstract] [Full Text] [Related]
36. Effects of the new antioxidant nicanartine in an experimental model of atherosclerosis.
Heinle H; Wülfroth P; Quack G; Lang F
Arzneimittelforschung; 1996 Oct; 46(10):956-9. PubMed ID: 8931887
[TBL] [Abstract][Full Text] [Related]
37. [New drugs registered in Austria].
Wien Klin Wochenschr; 1972 Mar; 84(12):200-1. PubMed ID: 5012428
[No Abstract] [Full Text] [Related]
38. [Use of pyrimidinol-carbamate in the therapy of peripheral obliterative arteriopathies].
Tardito E; Trezzi M; Papackaralambus D
Minerva Cardioangiol; 1970 Dec; 18(12):692-705. PubMed ID: 5532336
[No Abstract] [Full Text] [Related]
39. The effects of piridinol carbamate on hypercholesteremia and aortal damage produced by 5 days' application of Altman's diet to the rat.
Iwanowska J; Starzyński S; Kalinowska A
Pol J Pharmacol Pharm; 1980; 32(3):333-41. PubMed ID: 6974352
[TBL] [Abstract][Full Text] [Related]
40. [Clinical study of beta-pyridyl carbinol (Ronicol Timespan)].
Kobayashi K; Shibata M; Kato K; Kawaguchi S; Sasa R
Saishin Igaku; 1969 Dec; 24(12):2530-4. PubMed ID: 5363412
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
